awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
S10637-010-9625-X
S10637-010-9625-X
http://dx.doi.org/10.1007/S10637-010-9625-X
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P356
Q42770955-27CF2A6F-7DAA-49BD-B6CE-C866751CA6B8
P356
S10637-010-9625-X
http://dx.doi.org/10.1007/S10637-010-9625-X